BUZZ-Wells Fargo cuts Omnicell PT on lower 2025 revenue forecast

Reuters

13 Jan

BUZZ-Wells Fargo cuts <a href="https://laohu8.com/S/OMCL">Omnicell</a> PT on lower 2025 revenue forecast

** Brokerage Wells Fargo cuts PT of medical software company Omnicell OMCL.O to $40 from $49; maintains "equal weight" rating

** New PT is a 5.4% downside to the stock's last close

** Brokerage says OMCL is "poised to offer 2025 Product revenue guidance below consensus when it reports its 4Q24 results"

** Brokerage lowers 2025 product revenue forecast to $596 mln from $643 mln

** Brokerage says XT Extend offsetting low backlog coverage in 2025 "doesn't seem likely"

** OMCL's XT Extend is a healthcare tech upgrade for better security and user experience

** Brokerage says OMCL's decision to exit its Medimat Dispensing product line could drive "margin accretion" in 2025

** OMCL gained 19.2% in 2024

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2503305096"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2503305096\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2503305096?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-13 20:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2503305096","market":"us","top_or_hot":-1,"title":"BUZZ-Wells Fargo cuts Omnicell PT on lower 2025 revenue forecast","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Wells Fargo cuts <a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> PT on lower 2025 revenue forecast</title></head><body><p>** Brokerage Wells Fargo cuts PT of medical software company Omnicell <span>OMCL.O</span> to $40 from $49; maintains \"equal weight\" rating</p><p>** New PT is a 5.4% downside to the stock's last close</p><p>** Brokerage says OMCL is \"poised to offer 2025 Product revenue guidance below consensus when it reports its 4Q24 results\"</p><p>** Brokerage lowers 2025 product revenue forecast to $596 mln from $643 mln</p><p>** Brokerage says XT Extend <span>offsetting </span>low backlog coverage in 2025 \"doesn't seem likely\"</p><p>** OMCL's XT Extend is a healthcare tech upgrade for better security and user experience</p><p>** Brokerage <span>says </span>OMCL's decision to exit its Medimat Dispensing product line could drive \"margin accretion\" in 2025</p><p>** OMCL gained 19.2% in 2024</p><p> (Reporting by Kamal Choudhury in Bengaluru)</p><p> ((Kamal.Choudhury@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Wells Fargo cuts Omnicell PT on lower 2025 revenue forecast</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Wells Fargo cuts Omnicell PT on lower 2025 revenue forecast\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-01-13 20:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Wells Fargo cuts <a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> PT on lower 2025 revenue forecast</title></head><body><p>** Brokerage Wells Fargo cuts PT of medical software company Omnicell <span>OMCL.O</span> to $40 from $49; maintains \"equal weight\" rating</p><p>** New PT is a 5.4% downside to the stock's last close</p><p>** Brokerage says OMCL is \"poised to offer 2025 Product revenue guidance below consensus when it reports its 4Q24 results\"</p><p>** Brokerage lowers 2025 product revenue forecast to $596 mln from $643 mln</p><p>** Brokerage says XT Extend <span>offsetting </span>low backlog coverage in 2025 \"doesn't seem likely\"</p><p>** OMCL's XT Extend is a healthcare tech upgrade for better security and user experience</p><p>** Brokerage <span>says </span>OMCL's decision to exit its Medimat Dispensing product line could drive \"margin accretion\" in 2025</p><p>** OMCL gained 19.2% in 2024</p><p> (Reporting by Kamal Choudhury in Bengaluru)</p><p> ((Kamal.Choudhury@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OMCL","symbol_name":"Omnicell","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nL4N3O910N:1","article_id":"2503305096","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2503305096","pubTimestamp":1736772133,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Wells Fargo cuts Omnicell PT on lower 2025 revenue forecast** Brokerage Wells Fargo cuts PT of medical software company Omnicell OMCL.O to $40 from $49; maintains \"equal weight\" rating** New PT is a 5.4% downside to the stock's last close** Brokerage says OMCL is \"poised to offer 2025 Product revenue guidance below consensus when it reports its 4Q24 results\"** Brokerage lowers 2025 product revenue forecast to $596 mln from $643 mln** Brokerage says XT Extend offsetting low backlog coverage in 2025 \"doesn't seem likely\"** OMCL's XT Extend is a healthcare tech upgrade for better security and user experience** Brokerage says OMCL's decision to exit its Medimat Dispensing product line could drive \"margin accretion\" in 2025** OMCL gained 19.2% in 2024  ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"OMCL":"Omnicell"},"translate_title":"BUZZ-富国银行因2025年收入预测较低而削减Omnicell PT","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMCL":0.9},"content_text":"BUZZ-Wells Fargo cuts Omnicell PT on lower 2025 revenue forecast** Brokerage Wells Fargo cuts PT of medical software company Omnicell OMCL.O to $40 from $49; maintains \"equal weight\" rating** New PT is a 5.4% downside to the stock's last close** Brokerage says OMCL is \"poised to offer 2025 Product revenue guidance below consensus when it reports its 4Q24 results\"** Brokerage lowers 2025 product revenue forecast to $596 mln from $643 mln** Brokerage says XT Extend offsetting low backlog coverage in 2025 \"doesn't seem likely\"** OMCL's XT Extend is a healthcare tech upgrade for better security and user experience** Brokerage says OMCL's decision to exit its Medimat Dispensing product line could drive \"margin accretion\" in 2025** OMCL gained 19.2% in 2024 (Reporting by Kamal Choudhury in Bengaluru) ((Kamal.Choudhury@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}